Dorchester Minerals, L.P.
Dorchester Minerals, L.P. (DMLP) Financial Performance & Income Statement Overview
Analyze Dorchester Minerals, L.P. (DMLP) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Dorchester Minerals, L.P. (DMLP) Income Statement & Financial Overview
View the income breakdown for Dorchester Minerals, L.P. DMLP across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $43.16M | $39.71M | $53.47M | $37.36M |
| Cost of Revenue | $21.21M | $22.24M | $4.13M | $11.18M |
| Gross Profit | $21.96M | $17.47M | $49.34M | $26.18M |
| Gross Profit Ratio | $0.51 | $0.44 | $0.92 | $0.70 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $4.32M | $3.23M | $2.88M | $2.55M |
| Operating Expenses | $4.32M | $3.23M | $12.92M | $2.55M |
| Total Costs & Expenses | $25.52M | $25.47M | $17.06M | $13.73M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $17.96M | $10.04M | $7.67M |
| EBITDA | $17.64M | $32.20M | $46.45M | $31.29M |
| EBITDA Ratio | $0.41 | $0.81 | $0.87 | $0.84 |
| Operating Income | $17.64M | $14.24M | $36.41M | $23.63M |
| Operating Income Ratio | $0.41 | $0.36 | $0.68 | $0.63 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $17.64M | $14.24M | $36.41M | $23.63M |
| Income Before Tax Ratio | $0.41 | $0.36 | $0.68 | $0.63 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $17.64M | $14.24M | $35.14M | $23.63M |
| Net Income Ratio | $0.41 | $0.36 | $0.66 | $0.63 |
| EPS | $0.36 | $0.34 | $0.87 | $0.57 |
| Diluted EPS | $0.36 | $0.34 | $0.87 | $0.57 |
| Weighted Avg Shares Outstanding | $47.34M | $47.34M | $40.17M | $40.09M |
| Weighted Avg Shares Outstanding (Diluted) | $47.34M | $47.34M | $40.17M | $40.09M |
The company's financials show resilient growth, with revenue advancing from $37.36M in Q2 2024 to $43.16M in Q1 2025. Gross profit remained healthy with margins at 51% in Q1 2025 compared to 70% in Q2 2024. Operating income hit $17.64M last quarter, sustaining a consistent 41% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $17.64M. Net income rose to $17.64M, while earnings per share reached $0.36. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan